| 000 | 01698 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517204224.0 | ||
| 264 | 0 | _c20190924 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a2380-6591 | ||
| 024 | 7 |
_a10.1001/jamacardio.2018.0569 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNissen, Steven E | |
| 245 | 0 | 0 |
_aADCY9 Genetic Variants and Cardiovascular Outcomes With Evacetrapib in Patients With High-Risk Vascular Disease: A Nested Case-Control Study. _h[electronic resource] |
| 260 |
_bJAMA cardiology _c05 2018 |
||
| 300 |
_a401-408 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenylyl Cyclases _xgenetics |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBenzodiazepines _xtherapeutic use |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xgenetics |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCholesterol Ester Transfer Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPillai, Sreekumar G | |
| 700 | 1 | _aNicholls, Stephen J | |
| 700 | 1 | _aWolski, Kathy | |
| 700 | 1 | _aRiesmeyer, Jeffrey S | |
| 700 | 1 | _aWeerakkody, Govinda J | |
| 700 | 1 | _aFoster, Wendra M | |
| 700 | 1 | _aMcErlean, Ellen | |
| 700 | 1 | _aLi, Lin | |
| 700 | 1 | _aBhatnagar, Pallav | |
| 700 | 1 | _aRuotolo, Giacomo | |
| 700 | 1 | _aLincoff, A Michael | |
| 773 | 0 |
_tJAMA cardiology _gvol. 3 _gno. 5 _gp. 401-408 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamacardio.2018.0569 _zAvailable from publisher's website |
| 999 |
_c28165969 _d28165969 |
||